Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
ACS Chemical Biology|May 29, 2007
Mitomycin-DNA adducts induce p53-dependent and p53-independent cell death pathwaysErnest K Boamah, David E White, Kathryn E Talbott, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
A CANCER PERSISTENT DNA REPAIR CIRCUIT DRIVEN BY MDM2, MDM4 (MDMX), AND MUTANT P53 FOR RECRUITMENT OF MDC1 AND 53BP1 TO CHROMATINViola Ellison, Alla Polotskaia, Gu Xiao, et al.
Nucleic Acids Research|July 8, 2025
A cancer persistent DNA repair circuit driven by MDM2, MDM4 (MDMX), and mutant p53 for recruitment of MDC1 and 53BP1 on chromatinViola Ellison, Alla Polotskaia, Gu Xiao, et al.
NPJ Breast Cancer|February 25, 2017
Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancerWei-Gang Qiu, Alla Polotskaia, Gu Xiao, et al.
Chemical Research in Toxicology|June 12, 2010
DNA adducts of decarbamoyl mitomycin C efficiently kill cells without wild-type p53 resulting from proteasome-mediated degradation of checkpoint protein 1Ernest K Boamah, Angelika Brekman, Maria Tomasz, et al.
Nature Communications|January 3, 2024
p53 suppresses MHC class II presentation by intestinal epithelium to protect against radiation-induced gastrointestinal syndromeJianming Wang, Chun-Yuan Chang, Xue Yang, et al.
Chemical Research in Toxicology|December 5, 2008
Mapping DNA adducts of mitomycin C and decarbamoyl mitomycin C in cell lines using liquid chromatography/ electrospray tandem mass spectrometryManuel M Paz, Sweta Ladwa, Elise Champeil, et al.
Cancers|January 8, 2025
Chemokine CXCL12 Activates CXC Receptor 4 Metastasis Signaling Through the Upregulation of a CXCL12/CXCR4/MDMX (MDM4) AxisRusia Lee, Viola Ellison, Dominique Forbes, et al.
The Journal of Biological Chemistry|May 24, 2005
A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cellsNicoleta C Arva, Tamara R Gopen, Kathryn E Talbott, et al.
Cell Cycle (Georgetown, Tex.)|November 16, 2012
Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapyOlga Catalina Rodriguez, Sujatra Choudhury, Vamsi Kolukula, et al.
Pageof 5